Trisomy 21 (T21) confers increased gene dosage of the amyloid precursor protein (APP) and other proteins (BACE2, S100β, DYRK1A, RCAN1) involved in Alzheimer's disease (AD) pathology. The gene discussed is APP; the disease is Alzheimer disease.